Literature DB >> 31395386

In vitro cyst formation of ADPKD cells.

Madhulika Sharma1, Gail A Reif2, Darren P Wallace3.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder characterized by the relentless growth of numerous fluid-filled cysts in the kidneys. Mutations in PKD1 and PKD2, genes that encode polycystin 1 and 2, respectively, are responsible for most cases of ADPKD. Currently, the cellular mechanisms responsible for cyst formation remain poorly understood. In vitro models have been used by researchers to investigate cellular processes for cyst formation in carefully controlled experimental conditions. Madin-Darby canine kidney (MDCK) cells, a distal tubule epithelial cell line, were first used to form 3-dimensional (3-D) cysts within a hydrated collagen gel. This method was applied to epithelial cells cultured from cysts of human ADPKD kidneys, allowing investigators to study cellular mechanisms for cyst growth using cells that harbor the genetic mutations responsible for ADPKD in humans. Studies using ADPKD in vitro cysts have provided insight into cellular processes regulating cell proliferation, fluid secretion, and cell polarity. These assays were used to demonstrate the central role of cAMP agonists, such as arginine vasopressin, on cyst growth; and to test the effectiveness of potential therapeutic agents, including tolvaptan. Results obtained from in vitro cyst experiments demonstrate the translational value of cell model systems for investigating the mechanisms for cyst formation in human ADPKD. In this chapter, we describe protocols for growing ADPKD cells in a 3-D in vitro cyst assay and measuring total cyst volume by microscopy and image analysis.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease; Fluid secretion; In vitro models; Proliferation; Renal epithelial cells

Mesh:

Substances:

Year:  2019        PMID: 31395386     DOI: 10.1016/bs.mcb.2019.05.008

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  3 in total

1.  Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Rajni V Puri; Sireesha Yerrathota; Johnny Dinh-Phan; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; Hao Zhu; Subhashini Bolisetty; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  JCI Insight       Date:  2021-03-30

2.  Quinomycin A reduces cyst progression in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Emily A Daniel; Jessica Y Idowu; Wei Wang; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

Review 3.  An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs.

Authors:  Svenja Koslowski; Camille Latapy; Pierrïck Auvray; Marc Blondel; Laurent Meijer
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.